These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15788010)

  • 1. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
    Garcia-Morillo JS; Lorca RR; Bernabeu-Wittel M; Garcia-Junco PS; Andreu EP; de la Fuente JC
    J Intern Med; 2005 Apr; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda.
    Harper P; Floderus Y; Holmström P; Eggertsen G; Gåfvels M
    J Intern Med; 2004 Jun; 255(6):684-8. PubMed ID: 15147533
    [No Abstract]   [Full Text] [Related]  

  • 5. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
    Young LC
    Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
    J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.
    Kratka K; Dostalikova-Cimburova M; Michalikova H; Stransky J; Vranova J; Horak J
    Br J Dermatol; 2008 Sep; 159(3):585-90. PubMed ID: 18565178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
    Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
    Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.
    Roberts AG; Whatley SD; Morgan RR; Worwood M; Elder GH
    Lancet; 1997 Feb; 349(9048):321-3. PubMed ID: 9024376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda.
    Christiansen L; Bygum A; Thomsen K; Brandrup F; Hørder M; Petersen NE
    Clin Chem; 1999 Nov; 45(11):2025-6. PubMed ID: 10545080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
    Wolff CF; Armas RM; Frank J; Poblete PG
    Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda.
    Santos M; Clevers HC; Marx JJ
    N Engl J Med; 1997 May; 336(18):1327-8. PubMed ID: 9132598
    [No Abstract]   [Full Text] [Related]  

  • 14. Extremely rare association of HFE mutations with porphyria cutanea tarda in Japanese patients.
    Furuyama K; Kondo M; Hirata K; Fujita H; Sassa S
    Hepatology; 1999 Dec; 30(6):1532-3. PubMed ID: 10610355
    [No Abstract]   [Full Text] [Related]  

  • 15. C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria.
    Ivanova A; von Ahsen N; Adjarov D; Krastev Z; Oellerich M; Wieland E
    Hepatology; 1999 Dec; 30(6):1531-2. PubMed ID: 10610354
    [No Abstract]   [Full Text] [Related]  

  • 16. The most frequent HFE allele linked to porphyria cutanea tarda in Mediterraneans is His63Asp.
    Enriquez de Salamanca R; Morales P; Castro MJ; Rojo R; Gonzalez M; Arnaiz-Villena A
    Hepatology; 1999 Sep; 30(3):819-20. PubMed ID: 10490373
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload.
    Elder GH; Worwood M
    Hepatology; 1998 Jan; 27(1):289-91. PubMed ID: 9425949
    [No Abstract]   [Full Text] [Related]  

  • 18. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
    Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
    Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HFE gene S65C polymorphism is rare among Bulgarian porphyria cutanea tarda patients.
    von Ahsen N; Wieland E; Adjarov D; Krastev Z; Oellerich M; Ivanova A
    J Hepatol; 2001 Mar; 34(3):484-5. PubMed ID: 11322214
    [No Abstract]   [Full Text] [Related]  

  • 20. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.